This report examines the state-space trajectory of Absolute Neutrophils and Absolute Lymphocytes. Together, these markers define the Neutrophil to Lymphocyte Ratio (NLR).
| Component | Units | Logic | Reference | Optimal |
|---|---|---|---|---|
| Absolute Neutrophils | 10^3/uL | Raw Marker | 1.5 - 7.5 | 1.8 - 4.5 |
| Absolute Lymphocytes | 10^3/uL | Raw Marker | 1 - 4 | 1.5 - 2.8 |
| Neutrophil to Lymphocyte Ratio (NLR) | Ratio | \(NLR = \frac{Neutrophils_{abs}}{Lymphocytes_{abs}}\) | 1 - 3 | 1.2 - 2 |
This report utilizes State-Space Trajectory Analysis, a methodology first implemented by the author in 2015 to evaluate electrolyte flux and system stability over time (Seiter et al. 2015). By mapping the relationship between two dependent variables as well as a derived value, we move beyond the “Snapshot” model of medicine into a “2 Dimensional Temporal Visualization” of health. While contemporary research frameworks like STREAM (2026) have recently begun applying these principles to ICU monitoring (STREAM Research Group 2026), this report continues the author’s long-term development of trajectory-based clinical modeling.
| Date | Age | Absolute Neutrophils (10^3/uL) | Absolute Lymphocytes (10^3/uL) | Neutrophil to Lymphocyte Ratio (NLR) |
|---|---|---|---|---|
| 1998-05-12 | 32 | 3.19 | 1.35 | 2.36 |
| 2009-09-10 | 43 | 1.73 | 1.01 | 1.71 |
| 2009-12-09 | 44 | 1.20 | 0.95 | 1.26 |
| 2010-03-17 | 44 | 1.96 | 1.52 | 1.29 |
| 2010-07-21 | 44 | 1.56 | 1.22 | 1.28 |
| 2010-09-02 | 44 | 2.11 | 1.46 | 1.45 |
| 2010-10-25 | 44 | 1.55 | 1.40 | 1.11 |
| 2011-02-02 | 45 | 1.22 | 1.25 | 0.98 |
| 2011-06-28 | 45 | 1.37 | 1.44 | 0.95 |
| 2011-09-29 | 45 | 1.55 | 1.33 | 1.17 |
| 2013-04-18 | 47 | 2.45 | 1.54 | 1.59 |
| 2013-09-27 | 47 | 2.07 | 1.11 | 1.86 |
| 2016-05-28 | 50 | 3.02 | 1.64 | 1.84 |
| 2017-07-06 | 51 | 2.30 | 1.68 | 1.37 |
| 2017-11-17 | 51 | 2.59 | 1.54 | 1.68 |
| 2018-05-10 | 52 | 2.45 | 1.58 | 1.55 |
| 2018-11-09 | 52 | 2.30 | 1.60 | 1.44 |
| 2019-06-05 | 53 | 1.72 | 1.72 | 1.00 |
| 2020-04-09 | 54 | 1.86 | 1.96 | 0.95 |
| 2020-09-30 | 54 | 3.83 | 1.85 | 2.07 |
| 2021-07-23 | 55 | 2.06 | 1.91 | 1.08 |
| 2022-10-07 | 56 | 3.22 | 1.67 | 1.93 |
| 2023-08-10 | 57 | 2.26 | 1.73 | 1.31 |
| 2023-11-29 | 57 | 2.12 | 1.12 | 1.89 |
| 2024-03-05 | 58 | 2.76 | 1.70 | 1.62 |
| 2024-06-05 | 58 | 2.81 | 1.61 | 1.75 |
| 2025-08-06 | 59 | 4.18 | 2.16 | 1.94 |
Summary of historical distribution and the Z-score for the most recent result.
| Min | Q1.25% | Median | Mean | Q3.75% | Max | N | SD | Latest | Latest Z | |
|---|---|---|---|---|---|---|---|---|---|---|
| Absolute Neutrophils | 1.20 | 1.73 | 2.12 | 2.28 | 2.67 | 4.18 | 27 | 0.75 | 4.18 | 2.53 |
| Absolute Lymphocytes | 0.95 | 1.34 | 1.54 | 1.52 | 1.69 | 2.16 | 27 | 0.29 | 2.16 | 2.19 |
| Neutrophil to Lymphocyte Ratio (NLR) | 0.95 | 1.21 | 1.45 | 1.50 | 1.79 | 2.36 | 27 | 0.38 | 1.94 | 1.16 |
The Longitudinal History provides a traditional time-series view of each component. While the 2D State-Space reveals the 2 Dimensional Trajectory of the system, these 1D facets identify which specific component is driving the systemic shift. A trajectory move toward the high-risk ridge in the state-space can be traced here to either a surge in Innate activity (Neutrophils) or a depletion of Adaptive reserve (Lymphocytes).
The Neutrophil to Lymphocyte Ratio (NLR) is increasingly recognized in clinical literature as a sensitive marker for systemic inflammation and physiological stress. While standard laboratory reference ranges provide broad bounds, specific healthy population distributions and risk quartiles offer a higher-resolution “Audit” of immune status.
Current research indicates that in healthy, asymptomatic individuals, the mean NLR is approximately 1.65. This aligns closely with our established optimal “basin” of 1.2 – 2.0.
A 2026 study published in Nature utilizes a quartile-based approach to categorize inflammatory states. These thresholds provide a specific “Software” layer for interpreting where a trajectory sits on the metabolic landscape.
| Quartile | NLR Range | Clinical Interpretation |
|---|---|---|
| Q1 | < 1.65 | Healthy/Normal Range |
| Q2 | 1.65 – 2.13 | Upper End of Normal |
| Q3 | 2.13 – 2.74 | Mild Subclinical Inflammation |
| Q4 | > 2.74 | Elevated Inflammatory State |
Source: Nature (2026) Autoimmune-Risk Study - s41598-025-21188-y (Scientific Reports Research Group 2026)
To evolve this report from a “one-off” trajectory analysis into a comprehensive clinical tool, the following sub-sections are identified for future integration:
File Initially created: Saturday, April 11, 2026
File Updated for Neutrophil to Lymphocyte Ratio (NLR) Fine-Tuning:
Sunday, April 26, 2026
File Updated for Visual Refinement: Sunday, April 26, 2026
File knitted: Mon Apr 27 18:24:52 2026